Founded on September 23, 1993 as B.R.A.I.N. Biotechnology Research and Information Network GmbH in Darmstadt, Germany
Corporate History
From biotech pioneer to integrated group of companies
More than 30 years ago, graduates of the Technical University of Darmstadt founded the company "B.R.A.I.N.". Today we are an integrated group of companies and our next goal is to develop into a leading international company for specialty enzymes. Here you will find important milestones of the past years.
1993
1995
Move to Zwingenberg in a Bauhaus building (former Fissan factory, built in 1934)
1999
Spin-off of the pharmaceutical business into the wholly-owned subsidiary VISCUM AG
2000
Conversion to a stock corporation
2006
BRAIN and MIG Fonds close 12.5 million Euro expansion financing round
2008
Dr. Holger Zinke, founder and former CEO of B.R.A.I.N., receives the German Environmental Award 2008
2009
Acquisition of L.A. Schmitt GmbH, a cosmetics developer and manufacturer based in Ludwigsstadt, Germany
2010
Co-founded Enzymicals AG as a minority shareholder
2011
Majority acquisition of Monteil Cosmetics International GmbH, Düsseldorf, Germany
2012
BRAIN closes EUR 60 million financing round to expand its buy-and-build strategy
2013
Acquisition of natural compound chemistry specialist Analyticon Discovery GmbH, Potsdam, Germany
2014
Acquisition of majority interest in WeissBioTech GmbH
2016
IPO and listing on the Prime Standard of the Frankfurt Stock Exchange (ISIN DE0005203947 / WKN 520394). B.R.A.I.N. is the first bio-economy company to be listed on the Prime Standard of the Frankfurt Stock Exchange.
2018
Acquisition of shares in enzyme specialist Biocatalysts Ltd. in Cardiff, UK
Participation in the foundation of SolasCure Ltd.
2019
Sale of the shares in Monteil Cosmetics International GmbH
Expansion of production capacities at the Biocatalysts sites in Cardiff and WeissBioTech in Buettelborn
2021
Informing the public about the development of our proprietary CRISPR-Cas method
Acquisition of BIOSUN Biochemicals Inc., Tampa, Florida, USA
Change of name from B.R.A.I.N. Biotechnology Research and Information Network GmbH to BRAIN Biotech AG
2022
Acquisition of majority stake in Breatec B.V., Nieuwkuijk, The Netherlands
Publication of inaugural sustainability report and first ESG factsheet
2023
Full acquisition of Biocatalysts Ltd. and consolidation of the product business under its umbrella.
Two anniversaries: 30 years of BRAIN Biotech AG and 40 years of Biocatalysts Ltd.
2024
Merger of AnalytiCon Discovery GmbH with BRAIN Biotech AG